GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BTB Korea Co Ltd (XKRX:219750) » Definitions » EBIT

BTB Korea Co (XKRX:219750) EBIT : ₩-6,929.13 Mil (TTM As of Jun. 2024)


View and export this data going back to 2015. Start your Free Trial

What is BTB Korea Co EBIT?

BTB Korea Co's earnings before interest and taxes (EBIT) for the three months ended in Jun. 2024 was ₩-463.91 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2024 was ₩-6,929.13 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. BTB Korea Co's annualized ROC % for the quarter that ended in Jun. 2024 was -0.44%. BTB Korea Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was -9.13%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. BTB Korea Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was -16.34%.


BTB Korea Co EBIT Historical Data

The historical data trend for BTB Korea Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BTB Korea Co EBIT Chart

BTB Korea Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
Get a 7-Day Free Trial Premium Member Only -3,929.82 -13,792.59 -7,537.85 -10,188.25 -7,282.36

BTB Korea Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,475.66 -2,085.43 -4,804.14 424.35 -463.91

Competitive Comparison of BTB Korea Co's EBIT

For the Medical Instruments & Supplies subindustry, BTB Korea Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BTB Korea Co's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, BTB Korea Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where BTB Korea Co's EV-to-EBIT falls into.



BTB Korea Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-6,929.13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BTB Korea Co  (XKRX:219750) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

BTB Korea Co's annualized ROC % for the quarter that ended in Jun. 2024 is calculated as:

ROC % (Q: Jun. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2024 ) + Invested Capital (Q: Jun. 2024 ))/ count )
=-95.04 * ( 1 - -59.38% )/( (34369.524 + 34705.045)/ 2 )
=-151.474752/34537.2845
=-0.44 %

where

Invested Capital(Q: Mar. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=44860.784 - 2158.53 - ( 10335.06 - max(0, 9682.96 - 18015.69+10335.06))
=34369.524

Invested Capital(Q: Jun. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=39428.989 - 1310.655 - ( 5454.812 - max(0, 8721.092 - 12134.381+5454.812))
=34705.045

Note: The Operating Income data used here is four times the quarterly (Jun. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

BTB Korea Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Jun. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Mar. 2024  Q: Jun. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-1855.652/( ( (19683.02 + max(-453.511, 0)) + (19799.323 + max(1147.26, 0)) )/ 2 )
=-1855.652/( ( 19683.02 + 20946.583 )/ 2 )
=-1855.652/20314.8015
=-9.13 %

where Working Capital is:

Working Capital(Q: Mar. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(4359.458 + 1184.299 + 359.253) - (2158.53 + 0 + 4197.991)
=-453.511

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(4835.753 + 1301.098 + 417.677) - (1310.655 + 0 + 4096.613)
=1147.26

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Jun. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

BTB Korea Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Jun. 2024 )
=-6929.132/42393.081
=-16.34 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BTB Korea Co EBIT Related Terms

Thank you for viewing the detailed overview of BTB Korea Co's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


BTB Korea Co Business Description

Traded in Other Exchanges
N/A
Address
Room 1701, Bundang Suji U-Tower, 767, Sinsu-ro, Suji-gu, Gyeonggi-do, Yongin-si, KOR, 16827
GTG Wellness Co Ltd develops medical and beauty equipment. The company offers medical devices; and aesthetic, home care, and cosmetic products.

BTB Korea Co Headlines

No Headlines